Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study

scientific article published on 14 September 2013

Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.DRUGALCDEP.2013.09.003
P932PMC publication ID3960598
P698PubMed publication ID24095246

P50authorRebecca L AshareQ59859400
Caryn LermanQ66360703
Kosha RuparelQ80156402
Ruben C GurQ90481278
E Paul WileytoQ91919596
James W LougheadQ114417307
Ryan D HopsonQ114417310
P2093author name stringJeffrey N Valdez
Patricia M Goelz
P2860cites workAssociation of COMT Val108/158Met genotype with smoking cessationQ40134641
Some comments on frequently used multiple endpoint adjustment methods in clinical trialsQ41665319
Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokersQ43140809
Lack of association of a functional catechol-O-methyltransferase gene polymorphism with risk of tobacco smoking: results from a multicenter case-control studyQ43586657
Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphismQ44288862
Development of procedures for early screening of smoking cessation medications in humansQ46664319
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.Q48063516
Neuroimaging studies of practice-related change: fMRI and meta-analytic evidence of a domain-general control network for learningQ48720301
The early time course of smoking withdrawal effects.Q50935985
The effect of catechol-O-methyltransferase Met/Val functional polymorphism on smoking cessation: retrospective and prospective analyses in a cohort study.Q52294114
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brainQ24534089
Stress signalling pathways that impair prefrontal cortex structure and functionQ24606025
Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphismQ28282922
Improved optimization for the robust and accurate linear registration and motion correction of brain imagesQ29547542
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10Q29547745
Development and validation of brief measures of positive and negative affect: The PANAS scalesQ29614730
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophreniaQ29614929
Fast robust automated brain extractionQ29615078
A global optimisation method for robust affine registration of brain imagesQ29615079
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance QuestionnaireQ29615435
Varenicline improves mood and cognition during smoking abstinenceQ30483957
Practice induces function-specific changes in brain activityQ30493215
Temporal autocorrelation in univariate linear modeling of FMRI dataQ30665534
Genes and the parsing of cognitive processesQ30942053
Working memory deficits predict short-term smoking resumption following brief abstinenceQ33625059
COMT val108/158 met genotype affects neural but not cognitive processing in healthy individualsQ33648088
Association of catechol-O-methyltransferase with smoking cessation in two independent studies of womenQ34092978
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunctionQ34317550
Is there a common molecular pathway for addiction?Q34463226
Tolcapone improves cognition and cortical information processing in normal human subjectsQ34576438
Effects of abstinence from tobacco: valid symptoms and time courseQ34577868
The effects of the COMT Val108/158Met polymorphism on BOLD activation during working memory, planning, and response inhibition: a role for the posterior cingulate cortex?Q34662031
Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzymeQ34721779
Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbensQ35583364
Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawalQ35779281
COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibitionQ35859549
Lack of association between COMT and working memory in a population-based cohort of healthy young adultsQ36850559
Age-related differences in working memory deficits during nicotine withdrawalQ36983140
Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotypeQ37497959
Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settingsQ39420790
Effect of nicotine on the tobacco withdrawal syndromeQ39556613
P433issue3
P304page(s)852-856
P577publication date2013-09-14
P1433published inDrug and Alcohol DependenceQ5308875
P1476titleEffects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study
P478volume133

Reverse relations

cites work (P2860)
Q37195931A reverse factual analysis of the association between smoking and memory decline in China
Q28074860COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review
Q26744718Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies
Q41996915The Role of Working Memory for Cognitive Control in Anorexia Nervosa versus Substance Use Disorder
Q35421004Working memory-related neural activity predicts future smoking relapse

Search more.